Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine

26th March 2020 Uncategorised 0

The vaccine met all primary endpoints in adults aged 65 and older against Sanofi’s Fluzone Quadrivalent.

More: Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine
Source: News